Zhuohan Hu, Ph.D.
President and Chief Executive Officer
Zhuohan Hu, Ph.D. established Research Institute for Liver Diseases (Shanghai) Co., Ltd. In the summer of 2002.
Previously, Dr. Hu was Director of Pharmacokinetics and Drug Metabolism at In Vitro Technologies, Inc., Baltimore, Maryland, U. S. A. (2000-2002); Associate Director of Drug Metabolism at Huntingdon Life Sciences Inc., Princeton, New Jersey, USA (1999-2000), Research Leader of Pharmacokinetics and Drug Metabolism at BioChem Pharma, Inc. at Montreal, Quebec, Canada (1994-1999).
Dr. Hu obtained his College Diploma in Medicine (1976) from Shanghai First Medical College, Shanghai, China, MSc degree in Toxicology (1981) from Shanghai Medical University, and Ph. D. in Pharmacology (1992) from the University of Toronto.
Dr. Hu is an experienced scientist and dedicated teacher in drug metabolism and toxicology. He is one of the pioneers in the application of in vitro systems in the evaluation of human drug properties including metabolic fate, drug-drug interactions, and drug efficacy/toxicity in China. He is Principal Investigator for the Chinese government sponsored research projects of screening anti-viral candidates and Artificial Liver Dialysis. Dr. Hu has 30 publications and professional presentations. He is a frequent invited speaker and chairman in international symposia and conferences, and is VP of Chinese Society for Study of Xenobiotics (CSSX).